Enantioselective determination of aspartate and glutamate in biological samples by ultrasonic-assisted derivatization coupled with capillary electrophoresis and linked to Alzheimer’s disease progression

• Published in: Journal of Chromatography A 2018-05, Vol.1550, p.68-74
• Main Authors: Hsieh, Ya-Hui, Liao, Fang-Yi, Yang, Yuan-Han, Weng, Jing-Ru, Chen, Su-Hwei, Feng, Chia-Hsien
• Format: Article
• Language: English
• Subjects: Alzheimer’s disease; Aspartate; Chiral analysis; Glutamate; Ultrasonic-assisted derivatization
• ISSN: 0021-9673
• DOI: 10.1016/j.chroma.2018.03.041

•A CD-mediated CE method was proposed for the chiral analysis of Asp and Glu.•Ultrasound-assisted derivatization using 6-CFSE was proposed.•d/l-Asp and -Glu levels were determined in plasma and cerebrospinal fluid.•Plasma l-Asp was moderately negatively correlated with Alzheimer’s disease severity. A simple cyclodextrin-mediated capillary zone electrophoresis method equipped with a laser-induced fluorescence detector was developed for chiral analysis of the excitatory amino acids aspartate (Asp) and glutamate (Glu). Plasma and cerebrospinal fluid (CSF) samples were pretreated with centrifugal filter devices before analysis to remove high-molecular-weight proteins (molecular weight cut-off: 3000) and then derivatized using 10 mM 6-carboxyfluorescein N-hydroxysuccinimide ester in DMSO under sonication at 25 °C for 2 h. After the derivatization reaction, reacted samples were diluted 100-fold with 5-([4,6-dichlorotriazin-2-yl]amino)fluorescein hydrochloride (DTAF) solution and then hydrodynamically subjected to capillary electrophoresis (0.5 psi for 5 s, injection volume 8.27 nL). The separation buffer consisted of 50 mM borate buffer (pH 9.0) with 6 mM γ-CD and 0.1% polyvinylpyrrolidone, and the separation voltage was set at 20 kV. In the linearity calculations for the determination of d/l-Asp and d/l-Glu in plasma and CSF, a standard addition method was utilized to spike solutions with 0–20.0 μg mL−1l-Glu and 0–2.0 μg mL−1d-Glu and d/l-Asp to construct calibration curves. Correlation coefficients were above 0.998 for every analyte. The limits of detection (S/N = 3) for d/l-Asp and d/l-Glu standard solutions were 0.85–0.96 μg mL−1. The proposed method was applied successfully to determine d/l-Asp and d/l-Glu concentrations in the plasma and CSF samples of 26 patients with Alzheimer’s disease (AD), and the association between these concentrations and disease severity was investigated. Statistical analysis showed a moderately negative correlation (r = −0.158) between plasma l-Asp concentration and AD severity.